CTX-1211 is a selective, orally effective melanocortin MC4R agonist (EC50=0.38 nM). CTX-1211 can enhance the feeding suppression and weight loss effects induced by liraglutide (HY-P0014), and promote anorexia and weight loss activity. CTX-1211 is mainly used in the study of obesity and other metabolic disorders[1].
Molecular Weight:
1366.53
Formula:
C57H83N21O15S2
Target:
Melanocortin Receptor
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
